SCHEMBL4757863

SCHEMBL4757863

Nc1ccc(-c2c(N)nn3ccnc3c2N)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.35
KEAP1 Q14145 1/20 0.35
ADORA2A P29274 1/20 0.34
KDR P35968 1/20 0.34
JAK2 O60674 11/20 0.33
JAK3 P52333 11/20 0.33
ADK P55263 1/20 0.32
RAB9A P51151 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 2/20 0.31
TP53 P04637 2/20 0.31
CYP3A4 P08684 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
TNK2 Q07912 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4709570 0.88 KDM4E (0.38) NUDT1ADORA2AKDRJAK2JAK3
SCHEMBL4760688 0.87 NPC1 (0.41) NUDT1ADORA2AJAK2JAK3RAB9A
SCHEMBL5453382 0.86 KDM4E (0.37) ADORA2AKDRJAK2JAK3ADK
SCHEMBL4759759 0.73 JAK2 (0.35) NUDT1JAK2JAK3
SCHEMBL10756085 0.69 KDR (0.34) NUDT1KEAP1ADORA2AKDRJAK2
SCHEMBL3703475 0.69 JAK2 (0.55) JAK2JAK3NPC1MAPT
SCHEMBL5741027 0.66 SMPD3 (0.50) NUDT1JAK2JAK3
SCHEMBL14686167 0.63 JAK2 (0.42) JAK2JAK3KMT2AALDH1A1TP53
SCHEMBL3021469 0.62 NUDT1 (0.43) NUDT1ADORA2AJAK2
SCHEMBL5478336 0.61 RAB9A (0.59) NUDT1ADORA2ARAB9AKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928879-A2 FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS Brystol-Myers Squibb Company (US) 2008-06-11 EP disclosed
WO-2007038314-A2 FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-04-05 WO disclosed